Healthcare -
Drug Manufacturers - General - NYSE - CH
$ 97.53
-0.337 %
$ 191 B
Market Cap
17.02
P/E
NVS - RESEARCH & DEVELOPMENT
Research & Development NVS - Novartis AG
11.4 B
LAST VALUE
9.18%
2 YEAR CAGR
4.62%
5 YEAR CAGR
1.44%
10 YEAR CAGR